Biotechnology Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress – Galapagos (NASDAQ:GLPG) Read more
Biotechnology Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline – Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI) Read more
Stockmarkets A year after Iraq-Turkey pipeline halt, no progress to resume flows Reuters via biedexmarkets.com Read more
Biotechnology AstraZeneca Beefs Up Its Endocrine Disease Pipeline With Amolyt Pharma Deal Worth $1.05B – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline – First Wave BioPharma (NASDAQ:FWBI) Read more
Biotechnology Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline – Lipella Pharmaceuticals (NASDAQ:LIPO) Read more
Stockmarkets Baird starts Nuvalent shares with Outperform, highlights strong pipeline By biedexmarkets.com Read more
Biotechnology Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates – Athira Pharma (NASDAQ:ATHA) Read more
Biotechnology Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical Compounds – Enveric Biosciences (NASDAQ:ENVB) Read more
Biotechnology Neurology-Focused Axsome Therapeutics Reports Deeper Than Expected Q4 Loss, Updates Upcoming Pipeline Milestones – Axsome Therapeutics (NASDAQ:AXSM) Read more